Heights Capital Management’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
Other funds holding RANI
AIC
SL
Heights Capital Management's RANI Position: Q3 2026 in Review
Heights Capital Management held its Rani Therapeutics (RANI) position steady in Q3 2026 at 934,580 shares worth $739K. The position accounts for 0.15% of the portfolio, ranked #142.
Heights Capital Management first reported a position in RANI in Q2 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold RANI as of Q3 2026.
- Heights Capital Management held 934,580 shares of Rani Therapeutics worth $739K as of Q3 2026.
- Heights Capital Management left its Rani Therapeutics share count unchanged in Q3 2026.
- Rani Therapeutics made up 0.15% of Heights Capital Management's portfolio in Q3 2026, its #142 holding.
- Heights Capital Management first reported a position in Rani Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.
Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.